FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Speert

Research Profile

Disorders

Living Beings

Physiology

Phagocytosis

Procedures

Bacterial Typing Techniques

Chemicals & Drugs

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Brian A Reikie; Candice E Ruck; Amy L Slogrove; Kinga Smolen; David P Speert; Rozanne C M Adams; Mark F Cotton; Corena de Beer; Monika Esser; Kevin Ho; Heleen la Grange; Shalena Naidoo; Wolfgang Preiser; Tobias R Kollmann
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
Billie Velapatiño; Direk Limmathurotsakul; Sharon J Peacock; David P Speert
Identification of differentially expressed proteins from Burkholderia pseudomallei isolated during primary and relapsing melioidosis.
Brian A Reikie; Candice E Ruck; David P Speert; Rozanne C M Adams; Mark F Cotton; Corena de Beer; Monika Esser; Edgardo S Fortuno; Kevin Ho; Aleksandra Leligdowicz; Shalena Naidoo; Santoshan Pillay; Wolfgang Preiser; Tobias R Kollmann
Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Speert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian A Reikie; Candice E Ruck; Amy L Slogrove; Kinga Smolen; David P Speert; Rozanne C M Adams; Mark F Cotton; Corena de Beer; Monika Esser; Kevin Ho; Heleen la Grange; Shalena Naidoo; Wolfgang Preiser; Tobias R Kollmann
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
Clinical and vaccine immunology : CVI 2013;20(1):33-8.
2012: Billie Velapatiño; Direk Limmathurotsakul; Sharon J Peacock; David P Speert
Identification of differentially expressed proteins from Burkholderia pseudomallei isolated during primary and relapsing melioidosis.
Microbes and infection / Institut Pasteur 2012;14(4):335-40.
2012: Brian A Reikie; Candice E Ruck; David P Speert; Rozanne C M Adams; Mark F Cotton; Corena de Beer; Monika Esser; Edgardo S Fortuno; Kevin Ho; Aleksandra Leligdowicz; Shalena Naidoo; Santoshan Pillay; Wolfgang Preiser; Tobias R Kollmann
Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life.
PloS one 2012;7(9):e44763.
2012: James E A Zlosnik; L Cynthia Gunaratnam; David P Speert
Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.
Frontiers in cellular and infection microbiology 2012;2():67.
2012: Pascal M Lavoie; Mari Mahlman; David P Speert; Mikko Hallman; Aaron F Hirschfeld; Johanna Huusko; Thierry Lacaze-Masmonteil; Mihoko Ladd; Stuart E Turvey
Influence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants.
PloS one 2012;7(2):e31351.
2011: Inês N Silva; David P Speert; James E A Zlosnik; Jorg Becker; Ana S Ferreira; Ji He; Dalila Mil-Homens; Leonilde M Moreira
Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
Microbiology (Reading, England) 2011;157(Pt 11):3124-37.
2010: Pascal M Lavoie; Qing Huang; Elyse Jolette; Mihoko Whalen; Anne Monique Nuyt; Francois Audibert; David P Speert; Thierry Lacaze-Masmonteil; Hugo Soudeyns; Tobias R Kollmann
Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.
The Journal of infectious diseases 2010;202(11):1754-63.
2010: Tyler B M Hickey; Hermann J Ziltener; David P Speert; Richard W Stokes
Mycobacterium tuberculosis employs Cpn60.2 as an adhesin that binds CD43 on the macrophage surface.
Cellular microbiology 2010;12(11):1634-47.
2010: James Zlosnik; David P Speert
The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis.
The Journal of infectious diseases 2010;202(5):770-81.
2010: fang xie; Yuxiang Hu; David P Speert; Stuart E Turvey; Gang Peng; Deborah M Money; Laura A Magee; Peter von Dadelszen
Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis.
Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy 2010;29(4):390-8.
2010: Kelly L Brown; Reza Falsafi; Winnie Kum; Pamela Hamill; Jennifer L Gardy; Donald J Davidson; Stuart Turvey; Brett B Finlay; David P Speert; Robert E W Hancock
Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity.
Journal of translational medicine 2010;8():6.
2009: Tyler B M Hickey; Lisa M Thorson; David P Speert; Mamadou Daffé; Richard W Stokes
Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages.
Infection and immunity 2009;77(8):3389-401.
2009: Elke Vanlaere; Adam Baldwin; Dirk Gevers; Deborah Henry; Evie De Brandt; John J LiPuma; Eshwar Mahenthiralingam; David P Speert; Christopher G Dowson; Peter Vandamme
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
International journal of systematic and evolutionary microbiology 2009;59(Pt 1):102-11.
2008: Kelly L Brown; Johan Bylund; Kelly L MacDonald; George X Song-Zhao; Melissa R Elliott; Reza Falsafi; Robert E W Hancock; David P Speert
ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease.
Clinical immunology (Orlando, Fla.) 2008;129(1):90-102.
2008: Kelly L MacDonald; David P Speert
Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells.
Cellular microbiology 2008;10(10):2138-49.
2008: Elke Vanlaere; John J LiPuma; Adam Baldwin; Deborah Henry; Evie De Brandt; Eshwar Mahenthiralingam; David P Speert; Chris Dowson; Peter Vandamme
Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.
International journal of systematic and evolutionary microbiology 2008;58(Pt 7):1580-90.
2008: James Zlosnik; Trevor J Hird; Monica C Fraenkel; Leonilde M Moreira; Deborah A Henry; David P Speert
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.
Journal of clinical microbiology 2008;46(4):1470-3.
2008: Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Chris Pope; David J Waine; Deborah A Henry; David P Speert; Phil Carter; Peter Vandamme; John J LiPuma; Christopher G Dowson
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.
Journal of clinical microbiology 2008;46(1):290-5.
2007: Stuart E Turvey; David P Speert
Recurrent systemic pneumococcal disease and IRAK4 deficiency.
The Pediatric infectious disease journal 2007;26(11):1074; author reply 1074.
2007: Robert Ernst; Samuel M Moskowitz; Julia Emerson; Gretchen M Kraig; Kristin N Adams; Megan D Harvey; Bonnie W Ramsey; David P Speert; Jane L Burns; Samuel I Miller
Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
The Journal of infectious diseases 2007;196(7):1088-92.
2007: David J Waine; Deborah A Henry; Adam Baldwin; David P Speert; David Honeybourne; Eshwar Mahenthiralingam; Christopher G Dowson
Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2007;6(3):215-9.
2007: Johan Bylund; Kelly L MacDonald; Kelly L Brown; Piotr M Mydel; L Vincent Collins; Robert E W Hancock; David P Speert
Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B.
European journal of immunology 2007;37(4):1087-96.
2007: Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Peter Vandamme; John R Govan; David J Waine; John J LiPuma; Luigi Chiarini; Claudia Dalmastri; Deborah A Henry; David P Speert; David Honeybourne; Martin C J Maiden; Christopher G Dowson
Environmental Burkholderia cepacia complex isolates in human infections.
Emerging infectious diseases 2007;13(3):458-61.
2007: Jacqueline W Chung; David P Speert
Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host.
Microbiology (Reading, England) 2007;153(Pt 1):206-14.
2006: Donald J Davidson; Andrew J Currie; Dawn Bowdish; Kelly L Brown; Carrie M Rosenberger; Rebecca C Ma; Johan Bylund; Paul A Campsall; Anne Puel; Capucine Picard; Jean-Laurent Casanova; Stuart E Turvey; Robert E W Hancock; Rebecca S Devon; David P Speert
IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(11):8202-11.
2006: Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(22):8487-92.
2006: Johan Bylund; Lee-Anna Burgess; Paola Cescutti; Robert Ernst; David P Speert
Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species.
The Journal of biological chemistry 2006;281(5):2526-32.
2006: Minesh Khashu; Horacio Osiovich; Deborah Henry; Aziz Al Khotani; Alfonso Solimano; David P Speert
Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit.
Pediatrics 2006;117(2):340-8.
2006: David P Speert
Bacterial infections of the lung in normal and immunodeficient patients.
Novartis Foundation symposium 2006;279():42-51; disussion 51-5, 216-9.
2005: Kun Yang; Anne Puel; Shenying Zhang; Céline Eidenschenk; Cheng-Lung KU; Armanda Casrouge; Capucine Picard; Horst von Bernuth; Brigitte Senechal; Sabine Plancoulaine; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; László Maródi; Donald Davidson; David P Speert; Chaim M Roifman; Ben-Zion Garty; Adrian Ozinsky; Franck J Barrat; Robert L Coffman; Richard L Miller; Xiaoxia Li; Pierre Lebon; Carlos Rodriguez-Gallego; Helen Chapel; Frederic Geissmann; Emmanuelle Jouanguy; Jean-Laurent Casanova
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses.
Immunity 2005;23(5):465-78.
2005: Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J LiPuma; Peter Vandamme; Christopher G Dowson
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.
Journal of clinical microbiology 2005;43(9):4665-73.
2005: davood mansouri; Parisa Adimi; Mehdi Mirsaedi; Nahal Mansouri; Payam Tabarsi; majid amiri; Hamid Reza Jamaati; Masoud Motavasseli; Noushin Baghaii; Ali Cheraghvandi; Reza Rouhi; Navid A Roozbahany; Soheila Zahirifard; Foroozan Mohammadi; Mohammad Reza Masjedi; Ali Akbar Velayati; Jean L Casanova; David P Speert; R Kevin Elwood; Robert Schellenberg; Stuart E Turvey
Primary immune deficiencies presenting in adults: seven years of experience from Iran.
Journal of clinical immunology 2005;25(4):385-91.
2005: Deborah A Lewis; Andrew Jones; Julian Parkhill; David P Speert; John R W Govan; John J LiPuma; Stephen Lory; A Kevin Webb; Eshwar Mahenthiralingam
Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.
American journal of respiratory cell and molecular biology 2005;33(1):56-64.
2005: Entesar Husain; Sue Whitehead; Annette Castell; Eva E Thomas; David P Speert
Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.
The Pediatric infectious disease journal 2005;24(6):563-6.
2005: Johan Bylund; Paul A Campsall; Rebecca C Ma; Barbara-Ann D Conway; David P Speert
Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3562-9.
2005: Johan Bylund; David Goldblatt; David P Speert
Chronic granulomatous disease: from genetic defect to clinical presentation.
Advances in experimental medicine and biology 2005;568():67-87.
2004: Tom Coenye; Deborah Henry; David P Speert; Peter Vandamme
Burkholderia phenoliruptrix sp. nov., to accommodate the 2,4,5-trichlorophenoxyacetic acid and halophenol-degrading strain AC1100.
Systematic and applied microbiology 2004;27(6):623-7.
2004: Karen K Chu; Kelly L MacDonald; Donald J Davidson; David P Speert
Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung.
Infection and immunity 2004;72(10):6142-7.
2004: Barbara-Ann D Conway; Karen K Chu; Johan Bylund; Eleonora Altman; David P Speert
Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice.
The Journal of infectious diseases 2004;190(5):957-66.
2004: David P Speert; Joanna B Goldberg
Burkholderia cepacia complex and cystic fibrosis: in search of the smoking gun.
American journal of respiratory and critical care medicine 2004;170(1):6-7.
2004: Andrew J Pollard; Andrew J Currie; Carrie M Rosenberger; John-Paul Heale; B Brett Finlay; David P Speert
Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates.
Cellular microbiology 2004;6(7):639-50.
2004: Paul A Campsall; Nicholas H C Au; Julie S Prendiville; David P Speert; Rusung Tan; Eva E Thomas
Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.
Journal of clinical microbiology 2004;42(4):1409-13.
2004: Andrew J Currie; Donald J Davidson; Gregor S D Reid; Simi Bharya; Kelly L MacDonald; Rebecca S Devon; David P Speert
Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling.
The Journal of pediatrics 2004;144(4):512-8.
2004: Dawn Bowdish; Donald J Davidson; David P Speert; Robert E W Hancock
The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3758-65.
2004: Donald J Davidson; Andrew J Currie; Gregor S D Reid; Dawn Bowdish; Kelly L MacDonald; Rebecca C Ma; Robert E W Hancock; David P Speert
The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(2):1146-56.
2003: Andrew J Currie; David P Speert; Donald J Davidson
Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion.
Seminars in respiratory and critical care medicine 2003;24(6):671-80.
2003: Jacqueline W Chung; Eleonora Altman; Terry J Beveridge; David P Speert
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse.
Infection and immunity 2003;71(2):904-9.
2002: David P Speert; Maureen E Campbell; Deborah A Henry; Ruth Milner; Fatma Taha; Anna Gravelle; A George F Davidson; Lawrence T K Wong; Eshwar Mahenthiralingam
Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.
American journal of respiratory and critical care medicine 2002;166(7):988-93.
2002: Andrew J Pollard; Gary Probe; Colleen Trombley; Annette Castell; Sue Whitehead; J Mark Bigham; Sylvie Champagne; Judith Isaac-Renton; Rusung Tan; Malcolm Guiver; Ray Borrow; David P Speert; Eva Thomas
Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak.
Archives of pathology & laboratory medicine 2002;126(10):1209-15.
2002: Barbara-Ann D Conway; Vicnays Venu; David P Speert
Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex.
Journal of bacteriology 2002;184(20):5678-85.
2002: David P Speert
Molecular epidemiology of Pseudomonas aeruginosa.
Frontiers in bioscience : a journal and virtual library 2002;7():e354-61.
2002: David P Speert
Case 1: assessment. Burkholderia cepacia.
Paediatric respiratory reviews 2002;3(3):273-4.
2002: David P Speert
Advances in Burkholderia cepacia complex.
Paediatric respiratory reviews 2002;3(3):230-5.
2002: Rajeev Soni; Guy Marks; Deborah A Henry; Michael Robinson; Carmel Moriarty; Stephen Parsons; Peter Taylor; Eshwar Mahenthiralingam; David P Speert; Peter T P Bye
Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic.
Respirology (Carlton, Vic.) 2002;7(3):241-5.
2002: Yoichi Hirakata; Ramakrishnan Srikumar; Keith Poole; Naomasa Gotoh; Takashi Suematsu; Shigeru Kohno; Shimeru Kamihira; Robert E W Hancock; David P Speert
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.
The Journal of experimental medicine 2002;196(1):109-18.
2002: Peter Vandamme; Deborah Henry; Tom Coenye; Sazini Nzula; Marc Vancanneyt; John J LiPuma; David P Speert; John R W Govan; Eshwar Mahenthiralingam
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
FEMS immunology and medical microbiology 2002;33(2):143-9.
2002: Karen K Chu; Donald J Davidson; T Keith Halsey; Jacqueline W Chung; David P Speert
Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection.
Infection and immunity 2002;70(5):2715-20.
2002: David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
Emerging infectious diseases 2002;8(2):181-7.
2002: D Greenberg; David P Speert; Eshwar Mahenthiralingam; Deborah A Henry; Maureen E Campbell; David W Scheifele
Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada.
Journal of clinical microbiology 2002;40(1):68-74.
2001: Eshwar Mahenthiralingam; Peter Vandamme; Maureen E Campbell; Deborah A Henry; A M Gravelle; Lawrence T K Wong; A George F Davidson; Pearce G Wilcox; B Nakielna; David P Speert
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(9):1469-75.
2001: Tom Coenye; Eshwar Mahenthiralingam; Deborah Henry; John J LiPuma; S Laevens; Monique Gillis; David P Speert; Peter Vandamme
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
International journal of systematic and evolutionary microbiology 2001;51(Pt 4):1481-90.
2001: John-Paul Heale; Andrew J Pollard; Richard W Stokes; D Simpson; A Tsang; Bonnie G Massing; David P Speert
Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa.
The Journal of infectious diseases 2001;183(8):1214-20.
2001: Andrew J Pollard; John-Paul Heale; A Tsang; Bonnie G Massing; David P Speert
Nonopsonic phagocytosis of Pseudomonas aeruginoas: insights from an infant with leukocyte adhesion deficiency.
The Pediatric infectious disease journal 2001;20(4):452-4.
2001: Tom Coenye; John J LiPuma; Deborah Henry; Bart Hoste; Katrien Vandemeulebroecke; Monique Gillis; David P Speert; Peter Vandamme
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
International journal of systematic and evolutionary microbiology 2001;51(Pt 2):271-9.
2001: Elan C Paluck; D Katzenstein; C James Frankish; C P Herbert; Ruth Milner; David P Speert; K Chambers
Prescribing practices and attitudes toward giving children antibiotics.
Canadian family physician Médecin de famille canadien 2001;47():521-7.
2001: Deborah A Henry; Eshwar Mahenthiralingam; Peter Vandamme; T Coenye; David P Speert
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
Journal of clinical microbiology 2001;39(3):1073-8.
2001: John-Paul Heale; David P Speert
Protein kinase C agonists enhance phagocytosis of P. aeruginosa by murine alveolar macrophages.
Journal of leukocyte biology 2001;69(1):158-60.
2000: M Campbell; Eshwar Mahenthiralingam; David P Speert
Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.
Journal of clinical microbiology 2000;38(12):4614-5.
2000: D O Cheung; K Halsey; David P Speert
Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa.
Infection and immunity 2000;68(8):4585-92.
2000: D A Simpson; David P Speert
RpmA is required for nonopsonic phagocytosis of Pseudomonas aeruginosa.
Infection and immunity 2000;68(5):2493-502.
2000: Peter Vandamme; Eshwar Mahenthiralingam; B Holmes; Tom Coenye; Bart Hoste; P De Vos; Deborah Henry; David P Speert
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV).
Journal of clinical microbiology 2000;38(3):1042-7.
2000: Y Hirakata; B Brett Finlay; D A Simpson; S Kohno; S Kamihira; David P Speert
Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers.
The Journal of infectious diseases 2000;181(2):765-9.
2000: Eshwar Mahenthiralingam; T Coenye; Jacqueline W Chung; David P Speert; J R Govan; P Taylor; Peter Vandamme
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
Journal of clinical microbiology 2000;38(2):910-3.
1999: David P Speert; B Steen; K Halsey; E Kwan
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen.
Infection and immunity 1999;67(8):4027-32.
1999: Deborah Henry; M Campbell; C McGimpsey; A Clarke; L Louden; J L Burns; M H Roe; Peter Vandamme; David P Speert
Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
Journal of clinical microbiology 1999;37(4):1004-7.
1999: S Y Wong; L M Guerdoud; A Cantin; David P Speert
Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages.
Infection and immunity 1999;67(1):16-21.
1998: Richard W Stokes; Lisa M Thorson; David P Speert
Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(11):5514-21.
1997: M Dohil; Julie S Prendiville; R I Crawford; David P Speert
Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature.
Journal of the American Academy of Dermatology 1997;36(6 Pt 1):899-907.
1997: Eshwar Mahenthiralingam; D A Simpson; David P Speert
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.
Journal of clinical microbiology 1997;35(4):808-16.
1997: Deborah A Henry; Maureen E Campbell; John J LiPuma; David P Speert
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
Journal of clinical microbiology 1997;35(3):614-9.
1996: S Barghouthi; L M Guerdoud; David P Speert
Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells.
American journal of respiratory and critical care medicine 1996;154(6 Pt 1):1788-93.
1996: Eshwar Mahenthiralingam; M E Campbell; D A Henry; David P Speert
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.
Journal of clinical microbiology 1996;34(12):2914-20.
1996: Eshwar Mahenthiralingam; M E Campbell; J Foster; J S Lam; David P Speert
Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.
Journal of clinical microbiology 1996;34(5):1129-35.
1996: K D Everett; S Barghouthi; David P Speert
In vitro culture of murine peritoneal and alveolar macrophages modulates phagocytosis of Pseudomonas aeruginosa and glucose transport.
Journal of leukocyte biology 1996;59(4):539-44.
1995: Britt-Inger Marklund; David P Speert; Richard W Stokes
Gene replacement through homologous recombination in Mycobacterium intracellulare.
Journal of bacteriology 1995;177(21):6100-5.
1995: Eshwar Mahenthiralingam; David P Speert
Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum.
Infection and immunity 1995;63(11):4519-23.
1995: R W Stokes; David P Speert
Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1361-9.
1995: S Barghouthi; K D Everett; David P Speert
Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(7):3420-8.
1995: Eshwar Mahenthiralingam; M Campbell; David P Speert
Burkholderia cepacia in cystic fibrosis.
The New England journal of medicine 1995;332(12):819.
1995: D R Burdge; M A Noble; M E Campbell; V L Krell; David P Speert
Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(2):445-8.
1994: David P Speert; M Bond; R C Woodman; J T Curnutte
Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.
The Journal of infectious diseases 1994;170(6):1524-31.
1994: Eshwar Mahenthiralingam; M E Campbell; David P Speert
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.
Infection and immunity 1994;62(2):596-605.
1993: Richard W Stokes; I D Haidl; Wilfred A Jefferies; David P Speert
Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):7067-76.
1993: David P Speert
Phagocytosis of Pseudomonas aeruginosa by macrophages: receptor-ligand interactions.
Trends in microbiology 1993;1(6):217-21.
1993: David P Speert; M E Campbell; A G Davidson; L T Wong
Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis.
The Journal of infectious diseases 1993;167(1):226-9.
1992: David P Speert; S Gordon
Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose.
The Journal of clinical investigation 1992;90(3):1085-92.
1991: P Phillips; J C Forbes; David P Speert
Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy.
The Pediatric infectious disease journal 1991;10(7):536-9.
1991: David P Speert; L Thorson
Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.
Infection and immunity 1991;59(6):1893-8.
1991: Arnold S Bayer; David P Speert; S Park; J Tu; M Witt; C C Nast; D C Norman
Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.
Infection and immunity 1991;59(1):302-8.
1991: M E Conly; David P Speert
Human neonatal monocyte-derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production.
Biology of the neonate 1991;60(6):361-6.
1990: M G Pike; P K Wong; R Bencivenga; O Flodmark; David A Cabral; David P Speert; K Farrell
Electrophysiologic studies, computed tomography, and neurologic outcome in acute bacterial meningitis.
The Journal of pediatrics 1990;116(5):702-6.
1990: Arnold S Bayer; F Eftekhar; J Tu; C C Nast; David P Speert
Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa.
Infection and immunity 1990;58(5):1344-9.
1990: David P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
Journal of clinical microbiology 1990;28(2):188-94.
1989: David P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.
Journal of clinical microbiology 1989;27(11):2589-93.
1989: David P Speert; A G Davidson; L T Wong; W Paranchych
Communicability of Pseudomonas infections in patients with cystic fibrosis.
The Journal of pediatrics 1989;114(6):1068-9.
1988: F Eftekhar; David P Speert
Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.
Infection and immunity 1988;56(11):2788-93.
1988: M E Campbell; S W Farmer; David P Speert
New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390).
Journal of clinical microbiology 1988;26(9):1910-2.
1988: David P Speert; S D Wright; Samuel C. Silverstein; B Mah
Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.
The Journal of clinical investigation 1988;82(3):872-9.
1988: B L Pasloske; A M Joffe; Q Sun; K Volpel; W Paranchych; F Eftekhar; David P Speert
Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences.
Infection and immunity 1988;56(3):665-72.
1987: David P Speert; James Dimmick; G B Pier; J M Saunders; R E Hancock; N Kelly
An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis.
Pediatric research 1987;22(6):743-7.
1987: J L Battershill; David P Speert; Robert E W Hancock
Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.
Infection and immunity 1987;55(10):2531-3.
1987: David A Cabral; B A Loh; David P Speert
Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
Pediatric research 1987;22(4):429-31.
1987: G B Pier; J M Saunders; P Ames; M S Edwards; H Auerbach; J Goldfarb; David P Speert; S Hurwitch
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
The New England journal of medicine 1987;317(13):793-8.
1987: David A Cabral; O Flodmark; K Farrell; David P Speert
Prospective study of computed tomography in acute bacterial meningitis.
The Journal of pediatrics 1987;111(2):201-5.
1986: David P Speert; B A Loh; David A Cabral; I E Salit
Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity.
Infection and immunity 1986;53(1):207-12.
1986: W Paranchych; P A Sastry; K Volpel; B A Loh; David P Speert
Fimbriae (pili): molecular basis of Pseudomonas aeruginosa adherence.
Clinical and investigative medicine. Médecine clinique et experimentale 1986;9(2):113-8.
1985: D R Burdge; D Scheifele; David P Speert
Serious Pasteurella multocida infections from lion and tiger bites.
JAMA : the journal of the American Medical Association 1985;253(22):3296-7.
1985: David P Speert; B A Loh; David A Cabral; F Eftekhar
Opsonin-independent phagocytosis of Pseudomonas aeruginosa.
Antibiotics and chemotherapy 1985;36():88-94.
1984: David P Speert; F Eftekhar; M L Puterman
Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
Infection and immunity 1984;43(3):1006-11.